Clinical Trials Browser

Phase 1 × Terminated × Immunohistochemistry × Clear all

Ependymoma

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00747305 2015-10-22

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Phase 1 Terminated

17 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00989105 2012-02-28

Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer

Phase 1 Terminated

8 enrolled

Genitourinary

Prostatic Neoplasms

NCT00667901 2009-12-11

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Phase 1 Terminated

15 enrolled

Dermatologic

Melanoma

Clinical Trials

Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery